HSBC Holdings
PAHC icon

HSBC Holdings’s Phibro Animal Health PAHC Stock Holding History

HSBC Holdings’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,466
Closed -$841K – 3139
2026
Q1 		$841K Buy
15,466
+6,767
+78% +$322K ﹤0.01% 1959
2025
Q4 		$325K Sell
8,699
-9,249
-52% -$376K ﹤0.01% 2496
2025
Q3 		$727K Buy
17,948
+2,686
+18% +$88.7K ﹤0.01% 1925
2025
Q2 		$389K Sell
15,262
-1,778
-10% -$38.8K ﹤0.01% 2294
2025
Q1 		$363K Sell
17,040
-669
-4% -$15K ﹤0.01% 2258
2024
Q4 		$372K Buy
17,709
+6,169
+53% +$143K ﹤0.01% 2361
2024
Q3 		$260K Sell
11,540
-2,290
-17% -$44.2K ﹤0.01% 2445
2024
Q2 		$238K Buy
+13,830
New +$222K ﹤0.01% 2447
2022
Q4 		– Sell
-11,780
Closed -$159K – 3155
2022
Q3 		$159K Sell
11,780
-3,934
-25% -$67.9K ﹤0.01% 2687
2022
Q2 		$299K Sell
15,714
-485
-3% -$9.19K ﹤0.01% 2628
2022
Q1 		$327K Buy
+16,199
New +$327K ﹤0.01% 2696

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HSBC Holdings's PAHC Position: Q2 2026 in Review

HSBC Holdings sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 15,466 shares — an estimated $841K sold.

HSBC Holdings first reported a position in PAHC in Q1 2022 and held it in 11 quarters. The position peaked at $841K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • HSBC Holdings reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 15,466 Phibro Animal Health shares in Q2 2026, an estimated $841K.
  • HSBC Holdings first reported a position in Phibro Animal Health in Q1 2022 and held it in 11 quarters.
  • HSBC Holdings's Phibro Animal Health position peaked at $841K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.